|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
|
WO2010037001A2
(en)
|
2008-09-26 |
2010-04-01 |
Immune Disease Institute, Inc. |
Selective oxidation of 5-methylcytosine by tet-family proteins
|
|
ES2616051T3
(es)
|
2008-12-02 |
2017-06-09 |
Wave Life Sciences Japan, Inc. |
Método para la síntesis de ácidos nucleicos modificados en el átomo de fósforo
|
|
KR101885383B1
(ko)
|
2009-07-06 |
2018-08-03 |
웨이브 라이프 사이언시스 리미티드 |
신규한 핵산 프로드러그 및 그의 사용 방법
|
|
SI3338765T1
(sl)
|
2009-12-01 |
2019-05-31 |
Translate Bio, Inc. |
Derivat steroida za dostavo MRNA pri humanih genetskih boleznih
|
|
WO2012039448A1
(ja)
|
2010-09-24 |
2012-03-29 |
株式会社キラルジェン |
不斉補助基
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
RS64230B1
(sr)
|
2011-05-24 |
2023-06-30 |
BioNTech SE |
Individualizovane vakcine protiv kancera
|
|
DK3586861T3
(da)
|
2011-06-08 |
2022-04-25 |
Translate Bio Inc |
Lipidnanopartikelsammensætninger og fremgangsmåder til mrna-indgivelse
|
|
BR112014001244A2
(pt)
|
2011-07-19 |
2017-02-21 |
Wave Life Sciences Pte Ltd |
métodos para a síntese de ácidos nucléicos funcionalizados
|
|
US10023909B2
(en)
|
2011-12-13 |
2018-07-17 |
Oslo Universitetssykehus Hf |
Methods and kits for detection of methylation status
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
EP2834358A4
(en)
|
2012-04-02 |
2016-03-09 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
BR112014030677A2
(pt)
|
2012-06-08 |
2022-07-19 |
Shire Human Genetic Therapies |
distribuição pulmonar de mrna para células-alvo não-pulmonares
|
|
CN104684923B
(zh)
|
2012-07-13 |
2018-09-28 |
株式会社新日本科学 |
手性核酸佐剂
|
|
CN107011400B
(zh)
|
2012-07-13 |
2021-05-25 |
波涛生命科学有限公司 |
不对称辅助基团
|
|
US9982257B2
(en)
|
2012-07-13 |
2018-05-29 |
Wave Life Sciences Ltd. |
Chiral control
|
|
AU2013351542B2
(en)
|
2012-11-28 |
2018-08-09 |
BioNTech SE |
Individualized vaccines for cancer
|
|
ES2669512T3
(es)
|
2012-11-30 |
2018-05-28 |
Cambridge Epigenetix Limited |
Agente oxidante para nucleótidos modificados
|
|
PT2968586T
(pt)
|
2013-03-14 |
2018-11-13 |
Ethris Gmbh |
Composições de arnm de cftr e métodos e utilizações relacionados
|
|
DK2970456T3
(da)
|
2013-03-14 |
2021-07-05 |
Translate Bio Inc |
Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer
|
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
KR20150127582A
(ko)
|
2013-03-14 |
2015-11-17 |
샤이어 휴먼 지네틱 테라피즈 인크. |
4''-티오 개질된 뉴클레오티드를 갖는 리보핵산 및 관련 방법
|
|
JP6586075B2
(ja)
|
2013-03-14 |
2019-10-02 |
トランスレイト バイオ， インコーポレイテッド |
メッセンジャーｒｎａの精製方法
|
|
EP3578663A1
(en)
|
2013-03-15 |
2019-12-11 |
ModernaTX, Inc. |
Manufacturing methods for production of rna transcripts
|
|
WO2014152031A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Ribonucleic acid purification
|
|
EP2983804A4
(en)
|
2013-03-15 |
2017-03-01 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
|
SI2972360T1
(en)
|
2013-03-15 |
2018-08-31 |
Translate Bio, Inc. |
Synergistic improvement in the delivery of nucleic acids via mixed formulations
|
|
US10077439B2
(en)
|
2013-03-15 |
2018-09-18 |
Modernatx, Inc. |
Removal of DNA fragments in mRNA production process
|
|
WO2014180490A1
(en)
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
|
JP7019233B2
(ja)
|
2013-07-11 |
2022-02-15 |
モデルナティエックス インコーポレイテッド |
ＣＲＩＳＰＲ関連タンパク質をコードする合成ポリヌクレオチドおよび合成ｓｇＲＮＡを含む組成物ならびに使用方法
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
US10385088B2
(en)
|
2013-10-02 |
2019-08-20 |
Modernatx, Inc. |
Polynucleotide molecules and uses thereof
|
|
BR112016008832A2
(pt)
|
2013-10-22 |
2017-10-03 |
Shire Human Genetic Therapies |
Distribuição de mrna no snc e suas utilizações
|
|
ES2954366T3
(es)
|
2013-10-22 |
2023-11-21 |
Translate Bio Inc |
Terapia de ácido ribonucleico mensajero para la deficiencia de argininosuccinato sintetasa
|
|
EA034103B1
(ru)
|
2013-10-22 |
2019-12-27 |
Транслейт Био, Инк. |
СПОСОБ ЛЕЧЕНИЯ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
|
|
WO2015108046A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
|
JPWO2015108047A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
|
US10149905B2
(en)
|
2014-01-15 |
2018-12-11 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
|
|
CN113278617A
(zh)
|
2014-01-16 |
2021-08-20 |
波涛生命科学有限公司 |
手性设计
|
|
EP3636742A1
(en)
|
2014-04-25 |
2020-04-15 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|
|
US20170175129A1
(en)
*
|
2014-06-19 |
2017-06-22 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
WO2015196128A2
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
WO2016011222A2
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
WO2016045732A1
(en)
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
WO2016128060A1
(en)
|
2015-02-12 |
2016-08-18 |
Biontech Ag |
Predicting t cell epitopes useful for vaccination
|
|
EP3543339A1
(en)
*
|
2015-02-13 |
2019-09-25 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
PT3334828T
(pt)
|
2015-08-10 |
2020-12-18 |
Curevac Real Estate Gmbh |
Método para aumentar a replicação de uma molécula de dna circular
|
|
WO2017049286A1
(en)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a morpholino linker
|
|
US12109274B2
(en)
*
|
2015-09-17 |
2024-10-08 |
Modernatx, Inc. |
Polynucleotides containing a stabilizing tail region
|
|
WO2017059245A2
(en)
|
2015-09-30 |
2017-04-06 |
Trustees Of Boston University |
Deadman and passcode microbial kill switches
|
|
WO2017059902A1
(en)
|
2015-10-07 |
2017-04-13 |
Biontech Rna Pharmaceuticals Gmbh |
3' utr sequences for stabilization of rna
|
|
MA56219A
(fr)
|
2015-10-14 |
2022-04-20 |
Translate Bio Inc |
Modification d'enzymes apparentées à l'arn pour une production améliorée
|
|
ES2844180T3
(es)
|
2016-04-08 |
2021-07-21 |
Translate Bio Inc |
Acido nucleico codificante multimérico y usos del mismo
|
|
US20190382774A1
(en)
*
|
2016-05-18 |
2019-12-19 |
Modernatx, Inc. |
Polyribonucleotides containing reduced uracil content and uses thereof
|
|
US20190298657A1
(en)
*
|
2016-05-18 |
2019-10-03 |
Modernatx, Inc. |
Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
|
|
AU2017283479B2
(en)
|
2016-06-13 |
2023-08-17 |
Translate Bio, Inc. |
Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency
|
|
CA3029906A1
(en)
|
2016-07-07 |
2018-01-11 |
Rubius Therapeutics, Inc. |
Compositions and methods related to therapeutic cell systems expressing exogenous rna
|
|
CN116115629A
(zh)
|
2016-08-17 |
2023-05-16 |
菲克特生物科学股份有限公司 |
核酸产品及其施用方法
|
|
JP6842779B2
(ja)
*
|
2016-10-31 |
2021-03-17 |
国立大学法人岐阜大学 |
二本鎖核酸分子、およびその用途
|
|
WO2018157154A2
(en)
|
2017-02-27 |
2018-08-30 |
Translate Bio, Inc. |
Novel codon-optimized cftr mrna
|
|
EP3621637A1
(en)
|
2017-05-09 |
2020-03-18 |
Fundacion para la Investigacion Medica Aplicada |
Human porphobilinogen deaminase derived proteins and polynucleotides and uses thereof
|
|
MX2019013752A
(es)
|
2017-05-16 |
2020-07-20 |
Translate Bio Inc |
Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr optimizado en codones.
|
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
|
CA3084061A1
(en)
|
2017-12-20 |
2019-06-27 |
Translate Bio, Inc. |
Improved composition and methods for treatment of ornithine transcarbamylase deficiency
|
|
CN118421617A
(zh)
|
2018-08-24 |
2024-08-02 |
川斯勒佰尔公司 |
用于纯化信使rna的方法
|
|
US20220170062A1
(en)
*
|
2019-04-05 |
2022-06-02 |
Kyoto University |
Rna capping method, production method for modified rna, and modified rna
|
|
CN110287493B
(zh)
*
|
2019-06-28 |
2023-04-18 |
中国科学技术信息研究所 |
风险短语识别方法、装置、电子设备及存储介质
|
|
CN114222818A
(zh)
|
2019-07-02 |
2022-03-22 |
基础应用医学研究基金会 |
cPLA2e诱导剂及其用途
|
|
EP4017994A1
(en)
|
2019-08-22 |
2022-06-29 |
New England Biolabs, Inc. |
Cleavage of single stranded dna having a modified nucleotide
|
|
WO2021041267A1
(en)
|
2019-08-23 |
2021-03-04 |
New England Biolabs, Inc. |
Enzymatic rna capping method
|
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
|
KR20220124176A
(ko)
|
2019-12-06 |
2022-09-13 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 치환된 테트라하이드로푸란
|
|
TW202245800A
(zh)
|
2020-02-18 |
2022-12-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
TW202322824A
(zh)
|
2020-02-18 |
2023-06-16 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
CA3171648A1
(en)
|
2020-02-18 |
2021-08-26 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
|
JP2023535225A
(ja)
|
2020-07-24 |
2023-08-16 |
ストランド セラピューティクス インコーポレイテッド |
改変ヌクレオチドを含む脂質ナノ粒子
|
|
EP4034676A1
(en)
|
2020-07-30 |
2022-08-03 |
Cambridge Epigenetix Limited |
Compositions and methods for nucleic acid analysis
|
|
CN117177766A
(zh)
|
2020-10-26 |
2023-12-05 |
佩奇大学 |
疫苗平台
|
|
WO2022106860A1
(en)
|
2020-11-20 |
2022-05-27 |
Pécsi Tudományegyetem |
Recombinant peptides for use in therapy
|
|
EP4274846A1
(en)
|
2021-01-08 |
2023-11-15 |
Strand Therapeutics Inc. |
Expression constructs and uses thereof
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
CN112980954B
(zh)
*
|
2021-03-03 |
2022-02-25 |
首都医科大学宣武医院 |
一种预测神经退行性疾病风险的试剂盒及其用途
|
|
CN113041255B
(zh)
*
|
2021-04-13 |
2022-10-11 |
上海中医药大学 |
一种新发现miRNA–mRNA调控轴介导肺腺癌NCI-H1299细胞焦亡的方法
|
|
EP4323362A1
(en)
|
2021-04-16 |
2024-02-21 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
|
AR126073A1
(es)
|
2021-06-04 |
2023-09-06 |
Vertex Pharma |
N-(hidroxialquil(hetero)aril)tetrahidrofuran carboxamidas como moduladores de canales de sodio
|
|
WO2023023527A1
(en)
|
2021-08-18 |
2023-02-23 |
Gilead Sciences, Inc. |
Phospholipid compounds and methods of making and using the same
|
|
TW202332694A
(zh)
|
2021-10-07 |
2023-08-16 |
英商阿凡克塔生命科學公司 |
血清半衰期延長之ｐｄ－ｌ１結合多肽
|
|
TW202334196A
(zh)
|
2021-10-07 |
2023-09-01 |
英商阿法克塔生命科學有限公司 |
Pd-l1結合多肽
|
|
EP4419081A1
(en)
|
2021-10-22 |
2024-08-28 |
Sail Biomedicines, Inc. |
Mrna vaccine composition
|
|
AU2022398450A1
(en)
|
2021-11-23 |
2024-06-06 |
Sail Biomedicines, Inc. |
A bacteria-derived lipid composition and use thereof
|
|
EP4444345A2
(en)
|
2021-12-08 |
2024-10-16 |
ModernaTX, Inc. |
Herpes simplex virus mrna vaccines
|
|
WO2023122080A1
(en)
|
2021-12-20 |
2023-06-29 |
Senda Biosciences, Inc. |
Compositions comprising mrna and lipid reconstructed plant messenger packs
|
|
KR20230121575A
(ko)
|
2022-02-10 |
2023-08-18 |
주식회사 아피셀테라퓨틱스 |
Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도
|
|
US20230287376A1
(en)
|
2022-03-11 |
2023-09-14 |
New England Biolabs, Inc. |
Immobilized enzyme compositions and methods
|
|
WO2023177904A1
(en)
|
2022-03-18 |
2023-09-21 |
Modernatx, Inc. |
Sterile filtration of lipid nanoparticles and filtration analysis thereof for biological applications
|
|
WO2023183921A2
(en)
*
|
2022-03-24 |
2023-09-28 |
Nature's Toolbox, Inc. |
Methods and compositions for the enzymatic production of pseudouridine triphosphate
|
|
WO2023212618A1
(en)
|
2022-04-26 |
2023-11-02 |
Strand Therapeutics Inc. |
Lipid nanoparticles comprising venezuelan equine encephalitis (vee) replicon and uses thereof
|
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
|
WO2024044147A1
(en)
|
2022-08-23 |
2024-02-29 |
Modernatx, Inc. |
Methods for purification of ionizable lipids
|
|
WO2024050483A1
(en)
|
2022-08-31 |
2024-03-07 |
Modernatx, Inc. |
Variant strain-based coronavirus vaccines and uses thereof
|
|
WO2024102434A1
(en)
|
2022-11-10 |
2024-05-16 |
Senda Biosciences, Inc. |
Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
|
|
WO2024159172A1
(en)
|
2023-01-27 |
2024-08-02 |
Senda Biosciences, Inc. |
A modified lipid composition and uses thereof
|
|
WO2024163465A1
(en)
|
2023-01-30 |
2024-08-08 |
Modernatx, Inc. |
Epstein-barr virus mrna vaccines
|
|
WO2024200826A1
(en)
|
2023-03-30 |
2024-10-03 |
Ose Immunotherapeutics |
Lipid-based nanoparticle targeted at activated immune cells for the expression of immune cell inhibiting molecule and use thereof
|
|
WO2024200823A1
(en)
|
2023-03-30 |
2024-10-03 |
Ose Immunotherapeutics |
Lipid-based nanoparticle targeted at activated immune cells for the expression of immune cell enhancing molecule and use thereof
|
|
WO2024215721A1
(en)
|
2023-04-10 |
2024-10-17 |
Modernatx, Inc. |
Lyme disease vaccines
|
|
WO2024220625A1
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
|
|
WO2024220752A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Rna therapeutic compositions
|
|
WO2024220712A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Vaccine compositions
|
|
CN117820388A
(zh)
*
|
2023-11-20 |
2024-04-05 |
青岛糖智医药科技有限公司 |
一种用于mRNA合成的氘代加帽化合物及其制备方法和应用
|